HomeENOV • NYSE
Enovis Corp
$46.98
After Hours:
$46.98
(0.00%)0.00
Closed: Jan 31, 4:02:27 PM GMT-5 · USD · NYSE · Disclaimer
StockUS listed securityUS headquartered
Previous close
$47.51
Day range
$46.79 - $47.85
Year range
$38.27 - $65.03
Market cap
2.67B USD
Avg Volume
1.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
505.22M21.00%
Operating expense
291.70M17.80%
Net income
-31.52M-994.48%
Net profit margin
-6.24-804.35%
Earnings per share
0.7330.36%
EBITDA
77.06M51.71%
Effective tax rate
21.35%—
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
35.42M10.26%
Total assets
5.55B26.11%
Total liabilities
2.22B131.12%
Total equity
3.33B—
Shares outstanding
55.88M—
Price to book
0.80—
Return on assets
0.27%—
Return on capital
0.31%—
Net change in cash
(USD)Sep 2024Y/Y change
Net income
-31.52M-994.48%
Cash from operations
53.56M72.69%
Cash from investing
-58.42M-241.50%
Cash from financing
-148.00K98.92%
Net change in cash
-3.63M-901.66%
Free cash flow
-4.65M-107.05%
About
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world. Wikipedia
Founded
1995
Website
Employees
6,550
Search
Clear search
Close search
Google apps
Main menu